Latest Diabetes: Type II news
Adding Tirzepatide to Insulin Glargine Ups Glycemic Control in T2DM
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Comprehensive Approach Advised for Managing CV Risk in T2DM
posted January 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Inequities Seen in GLP-1 RA Use for Type 2 Diabetes in the U.S.
posted January 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Excess Cortisol From Benign Adrenal Tumors Ups Hypertension Risk
posted January 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
